Silencing c-Myc expression via siRNA in colon CSCs has been shown to reduce tumorigenicity in vivo, impair CD133+ cell invasion and migration in vitro, and inhibit tumor sphere formation. This evidence concerns the gene PROM1 and neoplasm.